For the correction of haemodynamic imbalances in low-perfusion circulatory insufficiency associated with myocardial infarction, trauma, septicaemia, cardiac failure and open heart surgery.
Dopamine hydrochloride is used for the correction of poor perfusion, low cardiac output, impending renal failure and shock associated with myocardial infarction, trauma, endotoxic septicaemia, open heart surgery and heart failure.
Dopamine is indicated in adults for the correction of haemodynamic imbalance present in: 1) Acute hypotension or shock associated with myocardial infarction, endotoxic septicaemia, trauma and renal failure. 2) As an adjunct after open heart surgery where there is persistent hypotension after correction of hypovolaemia. 3) In chronic cardiac decompensation as in congestive failure.
Dopamine is indicated in adults for the correction of haemodynamic imbalance present in: - Acute hypotension or shock associated with myocardial infarction, endotoxic septicaemia and trauma. - As an adjunct after open heart surgery where there is persistent hypotension after correction of hypovolaemia. - Acute exacerbations of chronic heart failure where is low cardiac output.
On 21 March 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a paediatric use marketing authorisation (PUMA) for the medicinal product Neoatricon, intended for treatment of hypotension in neonates, infants and children under 18 years of age. The applicant for this medicinal product is BrePco Biopharma Limited.